Hormone implants and tachyphylaxis
Article first published online: 19 AUG 2005
DOI: 10.1111/j.1471-0528.1990.tb02447.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b)
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 97, Issue 10, pages 917–921, October 1990
Additional Information
How to Cite
GARNETT, T., STUDD, J. W. W., HENDERSON, A., WATSON, N., SAVVAS, M. and LEATHER, A. (1990), Hormone implants and tachyphylaxis. BJOG: An International Journal of Obstetrics & Gynaecology, 97: 917–921. doi: 10.1111/j.1471-0528.1990.tb02447.x
Publication History
- Issue published online: 19 AUG 2005
- Article first published online: 19 AUG 2005
- Received 1 February 1990 Accepted 15 May 1990
- Abstract
- References
- Cited By
Summary. The serum oestradiol levels of 1388 women treated with hormone implants at a menopause clinic were reviewed in 1988. Thirty eight (3%) were found to be above 1750 pmol/1. Of these 38 women with supra physiological oestradiol levels 23 had started therapy for menopausal symptoms and 15 for the premenstrual syndrome (PMS). Of the 23 women treated for menopausal symptoms 11 had a history of psychiatric referral for depression and nine had undergone a surgical menopause. Nine of the 15 women with PMS had a history of psychiatric referral for depressive symptoms. We conclude that the women who attain supraphysiological levels of oestradiol on implant therapy have a high frequency of psychopathology or surgical menopause and may require higher oestradiol levels for adequate control of symptoms.

1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)